AIKO Biotechnology Company
AIKO Biotechnology develops therapeutic candidates for the treatment of pain, addiction, and side effects associated with opioid usage.
Industry:
PharmTech
Technology:
Drug Delivery
Estimated Revenue:
$10M to $50M
Headquarters:
Portland, Maine, United States
Employee Number:
1-10
Founded Date:
2006